The Cholangiocarcinoma Foundation has won a grant from Bayer to create a website and outreach to patients and doctors to let them know that all patients with the disease need to have their tumors sequenced, because there are existing medicines and clinical trials that may help patients with actionable mutations more than the standard of care.
I am the first to admit that I have a love-hate relationship with breast forms post-mastectomy. Every now and then, I do put one on. It comforts me to know that there are multiple options (especially for women who wear them regularly).
I've had many outward signs that let the world know I had cancer, so the latest addition to my wardrobe didn't exactly make it much more obvious.
Obesity may be to blame for increasing rates of certain cancers in young adults.
Here are tips for fellow cancer survivors to clear out cancer paraphernailia but keep important medical records.
Targeted drugs and immunotherapies are still on the horizon for people with cholangiocarcinoma, or bile duct cancer.
I feel fortunate to have my disease in this time of accelerated innovation
President Donald J. Trump announced his plan to amp up the fight against childhood cancer, and to lower prescription drug costs.
Ian W. Flinn, M.D., Ph.D., discusses the use of Copiktra, which was approved in September for patients with relapsed/refractory chronic lymphocytic leukemia.
After two bouts of cancer, happiness is a warm tush.
I had no idea learning to sit with people in their pain would help me learn how to deal with my own.
Splitting up Darzalex dosing had comparable results to standard dosing schedules in patients with myeloma.
One CURE contributor shares her hopes - and doubts - about recent cancer news.
If we are honest, I think most of us wonder deep down if we are going to live long enough to see the next grandchild, attend an important wedding or anniversary, or finish a project.
Researchers are evaluating the use of folate receptors to treat platinum-resistant ovarian cancer.
What can cancer centers boast that they do better than another?
From World Cancer Day to top performers and athletes, here is a quick overview of what is making headlines in the cancer space.
In topline findings from the phase 3 TITAN trial (NCT02489318) announced today by Janssen, Erleada (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved radiographic progression-free survival (rPFS) and overall survival (OS) versus placebo in patients with metastatic castration-sensitive prostate cancer.
Here are the top 5 CURE stories for January 2019.
A lot is still unknown about the causes of cholangiocarcinoma, because this type of cancer, which affects the bile ducts inside or outside the liver, is so rare.
The pressures of society can overwhelm the woman with breast cancer. These feelings of inadequacy and unacceptance can be compounded by the physical disfigurement left behind by breast cancer surgery.
The FDA has expanded the indication for Alimta (pemetrexed) injection in combination with Keytruda (pembrolizumab) and platinum-based chemotherapy for the first-line treatment of patients with metastatic nonsquamous non–small cell lung cancer (NSCLC) without EGFR or ALK alterations.
Only about 4 percent of adults with cancer are treated on clinical trials, according to one expert. Yet, those results are then applied to everybody.
$200,000 V Scholar Grant Awarded for Research Related to Blood Cancers
I vaguely knew what lymphedema was, and assumed it was something that only happened to breast cancer patients. But you know what they say about making assumptions.
Meeting others, learning tips, hearing from docs: breast cancer patients have it all when they get together.
Lymphedema can occur years after cancer, but exercise and lymphatic massages can help relieve symptoms.
Immunotherapy can cause some side effects that patients and practitioners should look out for.
While some high-risk patients with mantle cell lymphoma may benefit from aggressive initial therapy, a recent study found that this may not be necessary for others who could benefit from more targeted therapies.
